Maplelane Capital’s Albemarle ALB Stock Holding History

Maplelane Capital’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-230,000	Closed	-$29.4M	–	131
2017 Q4	$29.4M	Buy	+230,000	New	+$31.2M	0.64%	43

Other funds holding ALB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

GXMC

Global X Management Company New York $5.62B AUM 10.7% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Maplelane Capital's ALB Position: Q1 2018 in Review

Maplelane Capital sold out of Albemarle (ALB) in Q1 2018, closing a stake of 1,001 shares — an estimated $128K sold.

Maplelane Capital first reported a position in ALB in Q4 2017 and held it in 1 quarter. The position peaked at $128K in Q4 2017. 563 funds tracked by Wall St. Rank hold ALB as of Q1 2018.

Maplelane Capital reported no remaining Albemarle position as of Q1 2018 after selling out during the quarter.
Maplelane Capital sold 1,001 Albemarle shares in Q1 2018, an estimated $128K.
Maplelane Capital first reported a position in Albemarle in Q4 2017 and held it in 1 quarter.
Maplelane Capital's Albemarle position peaked at $128K in Q4 2017.
563 funds tracked by Wall St. Rank held Albemarle as of Q1 2018.

Based on Maplelane Capital's 13F filing for Q1 2018, filed 15 May 2018.